We are live on ! Find out more
FCOMV

Foresite Capital Opportunity Management V Portfolio holdings

AUM $33.3M
1-Year Est. Return 47.04%
This Fund
S&P 500
This Quarter Est. Return
-10.8%
1 Year Est. Return
-47.04%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$33.3M
AUM Growth
-$6.37M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
2.7 quarters
Top 10 Avg Time Held
2.7 quarters
Top 20 Avg Time Held
2.7 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$9.67M 29.04%
5,227,307
– –
2021 Q4
3 quarters
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$5.56M 16.71%
959,275
– –
2021 Q4
3 quarters
IRON icon
3
Disc Medicine
IRON
$2.38B
$3.99M 11.99%
81,171
– –
2021 Q4
3 quarters
CMPX icon
4
Compass Therapeutics
CMPX
$179M
$3.54M 10.64%
1,554,250
– –
2021 Q4
3 quarters
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$3.48M 10.46%
291,667
– –
2021 Q4
3 quarters
ACET icon
6
Adicet Bio
ACET
$52.5M
$2.42M 7.26%
10,625
– –
2021 Q4
3 quarters
QSI icon
7
Quantum-Si Incorporated
QSI
$335M
$1.74M 5.23%
633,626
– –
2021 Q4
3 quarters
HIMS icon
8
Hims & Hers Health
HIMS
$7.21B
$1.71M 5.13%
306,431
– –
2022 Q2
1 quarter
ENTA icon
9
Enanta Pharmaceuticals
ENTA
$364M
$1.18M 3.54%
22,750
– –
2022 Q1
2 quarters

Similar funds

Foresite Capital Opportunity Management V's Q3 2022 Portfolio in Review

As of Q3 2022, Foresite Capital Opportunity Management V held 9 positions worth $33.3M, down 16% from $39.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Foresite Capital Opportunity Management V opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Opportunity Management V's ten largest holdings make up 100% of its $33.3M portfolio in Q3 2022.
  • Foresite Capital Opportunity Management V opened 0 new positions and closed 0 in Q3 2022.
  • Foresite Capital Opportunity Management V's portfolio value fell 16% quarter-over-quarter to $33.3M.

Based on Foresite Capital Opportunity Management V's 13F filing for Q3 2022, filed 14 Nov 2022.